Published in Infect Immun on October 01, 2001
Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy. Clin Vaccine Immunol (2009) 1.20
Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect Immun (2005) 1.18
A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect Immun (2005) 1.16
A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2003) 1.11
Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun (2003) 1.06
Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun (2006) 1.00
Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells. Infect Immun (2004) 0.96
Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen. Infect Immun (2002) 0.89
Comparative proteome analysis of Brucella melitensis vaccine strain Rev 1 and a virulent strain, 16M. J Bacteriol (2002) 0.82
Enzymatic, immunological and phylogenetic characterization of Brucella suis urease. BMC Microbiol (2008) 0.82
Recent advances in Brucella abortus vaccines. Vet Res (2015) 0.81
An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice. Infect Immun (2005) 0.79
Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge. Genet Vaccines Ther (2010) 0.78
Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs. Clin Vaccine Immunol (2014) 0.76
Meta-Analysis and Advancement of Brucellosis Vaccinology. PLoS One (2016) 0.75
A Critical Role of Bacterioferritin in Salmonella pullorum-Induced IFN-β Expression in DF-1 Cells. Front Microbiol (2016) 0.75
Construction of an expression plasmid (vector) encoding Brucella melitensis outer membrane protein, a candidate for DNA vaccine. Rep Biochem Mol Biol (2013) 0.75
The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today (1996) 12.12
Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14
DNA vaccines. Annu Rev Immunol (1997) 5.05
DNA vaccines: immunology, application, and optimization*. Annu Rev Immunol (2000) 4.51
Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 3.82
Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol (1989) 2.73
Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am J Vet Res (1993) 2.68
Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun (1993) 2.33
Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect Immun (1993) 2.24
Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med (1996) 2.18
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 2.12
The Brucella abortus vaccine strain B19 carries a deletion in the erythritol catabolic genes. FEMS Microbiol Lett (1994) 2.07
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today (2000) 2.03
Pathogenesis of Brucella. Crit Rev Microbiol (1990) 1.97
DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med (1999) 1.93
Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infect Immun (1992) 1.86
Macrophages and Brucella. Immunol Ser (1994) 1.77
CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur J Immunol (1995) 1.75
DNA vaccines. Curr Opin Immunol (1996) 1.74
The role of CpG motifs in innate immunity. Curr Opin Immunol (2000) 1.74
Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine (1996) 1.70
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun (2001) 1.60
Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infect Immun (1994) 1.58
Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice. Infect Immun (1992) 1.55
Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol (1999) 1.53
Immunity and protection against Brucella abortus. Microbes Infect (2001) 1.50
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol (2000) 1.48
DNA vaccines: a key for inducing long-term cellular immunity. Curr Opin Immunol (2000) 1.42
Brucella species release a specific, protease-sensitive, inhibitor of TNF-alpha expression, active on human macrophage-like cells. J Immunol (1996) 1.40
Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins. Infect Immun (1994) 1.39
Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1997) 1.39
Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine. Vaccine (1994) 1.32
Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect Immun (1998) 1.29
DNA immunization. Trends Microbiol (1996) 1.26
Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J Immunol (1998) 1.20
Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun (2001) 1.19
Recent advances with recombinant bacterial vaccine vectors. Mol Med Today (2000) 1.11
Genetic adjuvants for DNA vaccines. Vaccine (2001) 1.05
Immune recognition of foreign DNA: a cure for bioterrorism? Immunity (1999) 1.05
Molecular basis of Brucella pathogenicity: an update. Microbiologia (1996) 1.05
Recent advances in brucellosis. J Med Microbiol (1997) 1.04
CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes. Eur J Immunol (2001) 1.01
Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB. J Med Microbiol (1997) 1.01
Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle. Infect Immun (1997) 0.99
Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine (1997) 0.98
DNA vaccines. Crit Rev Immunol (1998) 0.98
Characterization of a monoclonal antibody specific for Brucella smooth lipopolysaccharide and development of a competitive enzyme-linked immunosorbent assay to improve the serological diagnosis of brucellosis. Clin Diagn Lab Immunol (1996) 0.97
Cloning and sequencing of the bacterioferritin gene of Brucella melitensis 16M strain. FEBS Lett (1995) 0.95
Genetically engineered vaccines: an overview. Plasmid (1998) 0.92
Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses. Int Arch Allergy Immunol (1999) 0.89
Immunological response to the Brucella abortus GroEL homolog. Infect Immun (1996) 0.87
Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1. Vet Microbiol (2001) 0.85
Genetic vaccines: strategies for optimization. Pharm Res (1998) 0.82
Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. IV. Comparison between two methods of vaccination. Ann Rech Vet (1979) 0.81
New technologies for making vaccines. Vaccine (1999) 0.81
Current status of DNA vaccines in veterinary medicine. Adv Drug Deliv Rev (2000) 0.80
Immunotherapeutic gene transfer into muscle. Trends Immunol (2001) 0.79
Plasmid DNA: a new era in vaccinology. Biochem Pharmacol (1998) 0.78
Control of immune responses by gene immunization. Ann Med (1998) 0.77
DNA immunotherapeutics: new potential treatment modalities for allergic disease. Int Arch Allergy Immunol (1998) 0.76
European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg (1999) 17.03
Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg (1999) 7.29
Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J Cancer (2007) 5.38
The logistic EuroSCORE. Eur Heart J (2003) 4.94
Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg (1998) 3.45
Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology (2005) 2.69
Recent emergence of new variants of Yersinia pestis in Madagascar. J Clin Microbiol (1997) 2.53
Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke (2013) 2.44
Identification of Brucella spp. genes involved in intracellular trafficking. Cell Microbiol (2001) 2.26
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Classification of Brucella spp. isolated from marine mammals by DNA polymorphism at the omp2 locus. Microbes Infect (2001) 2.10
A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia (1992) 2.05
[Damage control laparotomy for haemorragic abdominal trauma. A retrospective multicentric study about 109 cases]. Ann Chir (2003) 1.97
Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages. Infect Immun (1998) 1.91
Monoclonal Antibodies against Pectin: Recognition of a Conformation Induced by Calcium. Plant Physiol (1989) 1.87
Molecular dipstick test for diagnosis of sleeping sickness. J Clin Microbiol (2006) 1.84
Effect of antibiotic therapy on the antibiotic resistance of faecal Escherichia coli in patients attending general practitioners. J Antimicrob Chemother (1994) 1.77
An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology (2012) 1.75
The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection. Cell Microbiol (2005) 1.73
Identification and characterization of in vivo attenuated mutants of Brucella melitensis. Mol Microbiol (2000) 1.71
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain (1999) 1.64
PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol (2013) 1.56
Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J Virol (1998) 1.53
Wildlife tuberculosis in South African conservation areas: implications and challenges. Vet Microbiol (2005) 1.52
[Individual and collective facilitators of and barriers to the use of clinical practice guidelines by physicians: a literature review]. Rev Epidemiol Sante Publique (2003) 1.52
The Paquid epidemiological program on brain ageing. Neuroepidemiology (1992) 1.51
Plasmodium falciparum induces apoptosis in human mononuclear cells. Infect Immun (1996) 1.50
Symmetric inertial confinement fusion implosions at ultra-high laser energies. Science (2010) 1.48
High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother (1997) 1.48
Pneumothoraces and chest tube placement after CT-guided transthoracic lung biopsy using a coaxial technique: incidence and risk factors. AJR Am J Roentgenol (1999) 1.46
Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma. J Urol (1997) 1.45
Predicting outcome after acute basilar artery occlusion based on admission characteristics. Neurology (2012) 1.45
[The Paquid research program on the epidemiology of dementia. Methods and initial results]. Rev Neurol (Paris) (1991) 1.43
Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology (2007) 1.42
Misdiagnosed malignancy in transplanted organs. Transpl Int (1993) 1.40
Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins. Infect Immun (1994) 1.39
Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1997) 1.39
Propofol versus thiopental by target controlled infusion in patients undergoing craniotomy. Minerva Anestesiol (2013) 1.39
Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice. Infect Immun (2003) 1.38
Control of pelvic symptoms in patients with rectal cancer and synchronous metastases. Gastroenterol Clin Biol (2009) 1.38
Phenotypic and molecular characterization of a Brucella strain isolated from a minke whale (Balaenoptera acutorostrata). Microbiology (1998) 1.38
A review of Brucella sp. infection of sea mammals with particular emphasis on isolates from Scotland. Vet Microbiol (2002) 1.36
Interferon production in mixed lymphocyte cell cultures. Infect Immun (1971) 1.34
Patient safety in developing countries: retrospective estimation of scale and nature of harm to patients in hospital. BMJ (2012) 1.33
Does EuroSCORE work in individual European countries? Eur J Cardiothorac Surg (2000) 1.32
Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer (2008) 1.32
Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of brucella melitensis 16M (wbk). Res Microbiol (2000) 1.27
Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains. J Clin Microbiol (2008) 1.25
Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study. Eur J Neurol (2013) 1.25
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy. Br J Cancer (2009) 1.22
Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect Immun (2001) 1.19
[Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989]. Arch Inst Pasteur Madagascar (1989) 1.19
Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin Diagn Lab Immunol (1995) 1.18
Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol (2002) 1.16
Immunoreactive Cu SOD and Mn SOD in the circulating blood cells from normal and trisomy 21 subjects. Biochem Biophys Res Commun (1981) 1.16
Determinants of the geographical distribution of endemic giardiasis in Ontario, Canada: a spatial modelling approach. Epidemiol Infect (2004) 1.15
Trends in antimicrobial resistance of Salmonella isolated from animals, foods of animal origin, and the environment of animal production in Canada, 1994-1997. Microb Drug Resist (2001) 1.14
Percutaneous CT-guided biopsy of the lung: comparison between aspiration and automated cutting needles using a coaxial technique. Cardiovasc Intervent Radiol (2000) 1.14
A descriptive analysis of giardiasis cases reported in Ontario, 1990-1998. Can J Public Health (2001) 1.14
Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med (1997) 1.13
The use of outbreak information in the interpretation of clustering of reported cases of Escherichia coli O157 in space and time in Alberta, Canada, 2000-2002. Epidemiol Infect (2006) 1.13
Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies. Infect Immun (1997) 1.13
Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis (2001) 1.13
Transpedicular screwing of the seventh cervical vertebra: anatomical considerations and surgical technique. Surg Radiol Anat (2003) 1.13
Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib. Br J Cancer (2011) 1.13
Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache (1999) 1.13
Summary of workshop findings for leukocyte antigens of cattle. Vet Immunol Immunopathol (1991) 1.12
Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis (1999) 1.12
Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol (2008) 1.12
Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer. Br J Cancer (2010) 1.11
Motor cortex stimulation for pain control induces changes in the endogenous opioid system. Neurology (2007) 1.11
[Three dimensional gait analysis and controlling spastic foot on stroke patients]. Ann Readapt Med Phys (2003) 1.11
Descriptive analysis of endemic cryptosporidiosis cases reported in Ontario, 1996-1997. Can J Public Health (2001) 1.11
Spatial and temporal epidemiology of sporadic human cases of Escherichia coli O157 in Scotland, 1996-1999. Epidemiol Infect (2005) 1.11